Keyword: Magid Abou-Gharbia

Chemistry & Life Sciences

Trend Barometer of Specialty Chemicals Industry

16.07.2019 - The 34th and, so far, biggest edition of Chemspec Europe attracted a total of 4,295 trade visitors from 53 countries to the exhibition grounds of Messe Basel, Switzerland. During...

Markets & Companies

ChemSpec Europe 2018: Online Partnering Program Creates Smart Networking Opportunities

28.02.2018 - ChemSpec Europe 2018: The Fine and Specialty Chemicals exhibition, taking place 20 – 21 June 2018 at Koelnmesse in Cologne, Germany, is known for being a key marketplace for...

Chemistry & Life Sciences

Chemspec Europe 2017 in Munich bigger than ever

24.05.2017 - Chemspec Europe 2017 is just around the corner: The 32nd edition of the International Exhibition for Fine and Speciality Chemicals takes place from 31 May – 1 June 2017 at the...

Chemistry & Life Sciences

Chemspec Europe 2017 Show Preview now available

12.05.2017 - Chemspec Europe 2017 is the International Exhibition for Fine and Speciality Chemicals. From 31 May – 1 June 2017, about 390 exhibitors from 29 countries will meet at the Munich...

Chemistry & Life Sciences

Chemspec Europe 2017: Register now for the International Exhibition for Fine and Speciality Chemicals

12.04.2017 - Less than two months to go until the international experts of the fine and speciality chemicals industry meet in Munich. From 31 May – 1 June 2017, about 350 exhibitors from 24...

Chemistry & Life Sciences

Chemspec Europe 2017

17.03.2017 - Chemspec Europe, the International Exhibition for Fine and Speciality Chemicals, makes a return to Munich for its 32nd edition. From 31 May – 1 June 2017, manufacturers, suppliers...

Chemistry & Life Sciences

Addressing The Pharma Innovation Gap

13.06.2016 - Since the beginning of the 21st century, pharma M&A activity has exploded. Mergers and acquisitions, layoffs, and outsourcing of research and manufacturing have become common place...

Strategy & Management

Discovering the Future of Pharma

30.09.2014 - Dramatic changes to the scientific and business environments have made it impossible for pharmaceutical companies to continue operating as they have in the past. A perceived...